Dietary synergies in appetite control: distal gastrointestinal tract (Q36576609)

15 August 2017

1 reference

title

Dietary synergies in appetite control: distal gastrointestinal tract (English)

1 reference

15 August 2017

1 reference

1

Stephen C Woods

1 reference

15 August 2017

1 July 2006

1 reference

15 August 2017

1 reference

15 August 2017

14 Suppl 4

1 reference

15 August 2017

171S-178S

1 reference

Leptin action in the forebrain regulates the hindbrain response to satiety signals.

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Expression of ileal glucagon and peptide tyrosine-tyrosine genes. Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Gastrointestinal hormones and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central nervous system control of food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Signals that regulate food intake and energy homeostasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Leptin amplifies the feeding inhibition and neural activation arising from a gastric nutrient preload.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central insulin enhances sensitivity to cholecystokinin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Low plasma leptin levels contribute to diabetic hyperphagia in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The economics of the law of effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The relation between meal size and the time between meals: effects of cage complexity and food cost

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The eating paradox: how we tolerate food

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The psychobiology of meals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The house economist and the eating paradox.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Nutritional implications of the cephalic-phase reflexes: endocrine responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Mind over metabolism: the cephalic phase in relation to non-insulin-dependent diabetes and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Taste, olfactory, and food texture processing in the brain, and the control of food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Absence of satiety during sham feeding in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Cholecystokinin suppresses sham feeding in the rhesus monkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Changes in the satiating effect of cholecystokinin over repeated trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Urges to eat and drink in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Exenatide: from the Gila monster to the pharmacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Gut peptides in the treatment of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

A role for glucagon-like peptide-1 in the central regulation of feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide-1 and satiety.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide-1: a potent regulator of food intake in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Central pre-proglucagon derived peptides: opportunities for treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian h

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Is parental control over children's eating associated with childhood obesity? Results from a population-based sample of third graders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Distribution and postprandial release of porcine peptide YY.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Gut hormone PYY(3-36) physiologically inhibits food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The gut hormone peptide YY regulates appetite.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Inhibition of food intake in obese subjects by peptide YY3-36

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Distribution of pancreatic polypeptide and peptide YY

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide-YY in the dog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Fat-induced ileal brake in the dog depends on peptide YY.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Suppression of peptide YY-induced hyperphagia by terbutaline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Peptide YY: a key mediator of orexigenic behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Peptides as central regulators of feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

PYY3-36 as an anti-obesity drug target.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Obesity wars: molecular progress confronts an expanding epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

The role of apolipoprotein A-IV in the regulation of food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Apolipoprotein A-IV, food intake, and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

31 March 2020

Ingested fat and satiety

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Neuropeptide Y and lipid increase apolipoprotein AIV gene expression in rat hypothalamus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Enterostatin suppresses food intake following injection into the third ventricle of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensory-specific satiety

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

inferred from DOI database lookup

7 January 2021

based on heuristic

Learning and tolerance to the intake suppressive effect of cholecystokinin in rats.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.301

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2006.301

1 reference

15 August 2017

1 reference

PubMed ID

16931502